Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytosis, Langerhans-Cell × Busulfan × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 17 Myelodysplastic Syndromes 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Myeloproliferative Disorders 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Hematologic Neoplasms 5 Leukemia, Biphenotypic, Acute 4 Neuroblastoma 3 Lymphoproliferative Disorders 3 Lymphoma 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Lymphoid 3 Leukemia 3 Primary Myelofibrosis 2 Preleukemia 2 Precancerous Conditions 2 Neoplasms by Histologic Type 2 Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lymphatic Diseases 2 Leukemia, Myeloid 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, B-Cell 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Hodgkin Disease 2 Hematologic Diseases 2 Graft vs Host Disease 2

Interventions

X-Rays 3 Specimen Handling 3 Phantoms, Imaging 3 Nuclear Medicine Department, Hospital 3 Magnetic Resonance Spectroscopy 3 Biopsy 3 trametinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 dabrafenib 2 ulixertinib 1 tipifarnib 1 tazemetostat 1 selpercatinib 1 palbociclib 1 olaparib 1 larotrectinib 1 etoposide phosphate 1 Vemurafenib 1 Sirolimus 1 LY3023414 1 Genetic Testing 1 Etoposide 1 Cyclophosphamide 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡